![]() |
Trials |
Cross tumoral phase II clinical trial exploring crizotinib (PF-02341066) in patients with advanced tumors induced by causal alterations of ALK and/or METCancer type: Lymphoma, Sarcoma Phase: II Principal Investigator: Aamdal Steinar Country: NO Keywords: Norway, Oslo, Sarcoma, Lymfoma, Crizotinib, EORTC, CREATE Status: Inclusion completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01524926?term=CREATE&rank=1 |